Biopharmas raising money in public or private financings, including: Atai, Chemify, Citius, Disc Medicine, Exeliom, Faeth, Lexeo, Minerva, Pleopharma, Xortx.

Biopharmas raising money in public or private financings, including: Alto Neuroscience, Cardiol, Cyclana, Disc Medicine, Valink.

Step Pharma is financed to move its pipeline-in-a-product strategy forward on a broad front, after raising a €38 million (US$44.2 million) series C. That will see three ongoing trials testing the company’s potentially first-in-class, orally available cytidine triphosphate synthase 1 inhibitor, dencatistat, through to phase II in T-cell and B-cell lymphoma, in an ovarian, endometrial and lung cancer study, and in essential thrombocythemia.

Biopharmas raising money in public or private financings, including: AB Science, C4, Praxis Precision Medicines, Rani.

Biopharmas raising money in public or private financings, including: Alzinova, C4, Conexeu, Peptilogics, Spyre, Veradermics.

Biopharmas raising money in public or private financings, including: Akari, Bexorg, Eyepoint, Mission, Omnix, Propanc, Step.

Biopharmas raising money in public or private financings, including: Candel, Enveric, Everzom, Maia, Spyre, Tr1x.